Titre:
  • Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Auteur:Early Breast Cancer Trialists' Collaborative Group (EBCTCG), C; Davies, J; Godwin, Richard; Gray, M.J.; Clarke, D; Cutter, S; Darby, P; McGale, Huade; Pan, C; Taylor, Yiwei; Wang, Mitch; Dowsett, James N; Ingle, R; Peto,
Informations sur la publication:Lancet, 378, 9793, page (771-784)
Statut de publication:Publié, 2011-08
Sujet CREF:Cancérologie
MeSH keywords:Antineoplastic Agents, Hormonal -- adverse effects -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- mortality -- pathology
Chemotherapy, Adjuvant
Female
Humans
Neoplasm Recurrence, Local -- prevention & control
Neoplasms, Second Primary -- chemically induced
Randomized Controlled Trials as Topic
Receptors, Estrogen -- metabolism
Receptors, Progesterone -- metabolism
Selective Estrogen Receptor Modulators -- adverse effects -- therapeutic use
Tamoxifen -- adverse effects -- therapeutic use
Note générale:Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0140-6736
info:doi/10.1016/S0140-6736(11)60993-8
info:pii/S0140-6736(11)60993-8
info:pmid/21802721
PMC3163848